These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
157 related articles for article (PubMed ID: 1396330)
1. Substitution of cysteine for selenocysteine in type I iodothyronine deiodinase reduces the catalytic efficiency of the protein but enhances its translation. Berry MJ; Maia AL; Kieffer JD; Harney JW; Larsen PR Endocrinology; 1992 Oct; 131(4):1848-52. PubMed ID: 1396330 [TBL] [Abstract][Full Text] [Related]
2. Recognition of UGA as a selenocysteine codon in type I deiodinase requires sequences in the 3' untranslated region. Berry MJ; Banu L; Chen YY; Mandel SJ; Kieffer JD; Harney JW; Larsen PR Nature; 1991 Sep; 353(6341):273-6. PubMed ID: 1832744 [TBL] [Abstract][Full Text] [Related]
3. Substitution of cysteine for selenocysteine in the catalytic center of type III iodothyronine deiodinase reduces catalytic efficiency and alters substrate preference. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2003 Jun; 144(6):2505-13. PubMed ID: 12746313 [TBL] [Abstract][Full Text] [Related]
4. Cloning and in vitro expression of the human selenoprotein, type I iodothyronine deiodinase. Mandel SJ; Berry MJ; Kieffer JD; Harney JW; Warne RL; Larsen PR J Clin Endocrinol Metab; 1992 Oct; 75(4):1133-9. PubMed ID: 1400883 [TBL] [Abstract][Full Text] [Related]
5. Substitution of cysteine for a conserved alanine residue in the catalytic center of type II iodothyronine deiodinase alters interaction with reducing cofactor. Kuiper GG; Klootwijk W; Visser TJ Endocrinology; 2002 Apr; 143(4):1190-8. PubMed ID: 11897672 [TBL] [Abstract][Full Text] [Related]
6. The role of the active site cysteine in catalysis by type 1 iodothyronine deiodinase. Sun BC; Harney JW; Berry MJ; Larsen PR Endocrinology; 1997 Dec; 138(12):5452-8. PubMed ID: 9389531 [TBL] [Abstract][Full Text] [Related]
7. Evidence that cysteine, not selenocysteine, is in the catalytic site of type II iodothyronine deiodinase. Berry MJ; Kieffer JD; Larsen PR Endocrinology; 1991 Jul; 129(1):550-2. PubMed ID: 1829034 [TBL] [Abstract][Full Text] [Related]
8. Characterization of recombinant Xenopus laevis type I iodothyronine deiodinase: substitution of a proline residue in the catalytic center by serine (Pro132Ser) restores sensitivity to 6-propyl-2-thiouracil. Kuiper GG; Klootwijk W; Morvan Dubois G; Destree O; Darras VM; Van der Geyten S; Demeneix B; Visser TJ Endocrinology; 2006 Jul; 147(7):3519-29. PubMed ID: 16601143 [TBL] [Abstract][Full Text] [Related]
9. Type I iodothyronine deiodinase is a selenocysteine-containing enzyme. Berry MJ; Banu L; Larsen PR Nature; 1991 Jan; 349(6308):438-40. PubMed ID: 1825132 [TBL] [Abstract][Full Text] [Related]
10. The role of selenocysteine 133 in catalysis by the human type 2 iodothyronine deiodinase. Buettner C; Harney JW; Larsen PR Endocrinology; 2000 Dec; 141(12):4606-12. PubMed ID: 11108274 [TBL] [Abstract][Full Text] [Related]
12. Type 3 lodothyronine deiodinase: cloning, in vitro expression, and functional analysis of the placental selenoenzyme. Salvatore D; Low SC; Berry M; Maia AL; Harney JW; Croteau W; St Germain DL; Larsen PR J Clin Invest; 1995 Nov; 96(5):2421-30. PubMed ID: 7593630 [TBL] [Abstract][Full Text] [Related]
13. Selenocysteine confers the biochemical properties characteristic of the type I iodothyronine deiodinase. Berry MJ; Kieffer JD; Harney JW; Larsen PR J Biol Chem; 1991 Aug; 266(22):14155-8. PubMed ID: 1830583 [TBL] [Abstract][Full Text] [Related]
14. Molecular cloning of the selenocysteine-containing enzyme type I iodothyronine deiodinase. Berry MJ; Larsen PR Am J Clin Nutr; 1993 Feb; 57(2 Suppl):249S-255S. PubMed ID: 8427198 [TBL] [Abstract][Full Text] [Related]
15. Characterization of an iodothyronine 5'-deiodinase in gilthead seabream (Sparus auratus) that is inhibited by dithiothreitol. Klaren PH; Haasdijk R; Metz JR; Nitsch LM; Darras VM; Van der Geyten S; Flik G Endocrinology; 2005 Dec; 146(12):5621-30. PubMed ID: 16166227 [TBL] [Abstract][Full Text] [Related]
16. Dual mechanisms of regulation of type I iodothyronine 5'-deiodinase in the rat kidney, liver, and thyroid gland. Implications for the treatment of hyperthyroidism with radiographic contrast agents. St Germain DL J Clin Invest; 1988 May; 81(5):1476-84. PubMed ID: 2835397 [TBL] [Abstract][Full Text] [Related]
17. The type I iodothyronine 5'-deiodinase messenger ribonucleic acid is localized to the S3 segment of the rat kidney proximal tubule. Lee WS; Berry MJ; Hediger MA; Larsen PR Endocrinology; 1993 May; 132(5):2136-40. PubMed ID: 8477661 [TBL] [Abstract][Full Text] [Related]
18. Retinoids stimulate type I iodothyronine 5'-deiodinase activity in human follicular thyroid carcinoma cell lines. Schreck R; Schnieders F; Schmutzler C; Köhrle J J Clin Endocrinol Metab; 1994 Sep; 79(3):791-8. PubMed ID: 8077363 [TBL] [Abstract][Full Text] [Related]
19. Cloning and characterization of type III iodothyronine deiodinase from the fish Oreochromis niloticus. Sanders JP; Van der Geyten S; Kaptein E; Darras VM; Kühn ER; Leonard JL; Visser TJ Endocrinology; 1999 Aug; 140(8):3666-73. PubMed ID: 10433225 [TBL] [Abstract][Full Text] [Related]